Christopher P. Lowe - Nov 16, 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
COO & Chief Financial Officer
Signature
/s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe
Stock symbol
QNCX
Transactions as of
Nov 16, 2021
Transactions value $
$66,900
Form type
4
Date filed
11/16/2021, 07:17 PM
Previous filing
Oct 7, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Options Exercise $66.9K +30K +50% $2.23 90K Nov 16, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Options Exercise $0 -30K -22.51% $0.00 103K Nov 16, 2021 Common Stock 30K $2.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.